People
Conrad Axelrod represents sophisticated asset managers and investors across the private funds spectrum. He counsels clients on the intersection of corporate, tax, regulatory, ERISA and finance matters that define the investment management industry.
Conrad has over 12 years' experience in US and European fund formation at market-leading law firms. His asset management experience encompasses closed-end and open-end fund formation in the private equity, hedge, credit, real estate, oil & gas, infrastructure, venture capital and litigation finance sectors. Conrad routinely advises on regulatory compliance and other governance aspects of co-investments, separate accounts and cross-border joint ventures. He also has significant experience negotiating and executing strategic transactions involving investment advisers, seed investments, fund recapitalizations and secondary portfolios.
LL.M., Humboldt University of Berlin
B.Sc., University of Tasmania
LL.B., University of Tasmania
England and Wales
New South Wales
New York
German
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
August 9, 2021
King & Spalding Team Closes a Variety of Esoteric Financings in Early 2021
December 2, 2020
K&S counsels MAG Mutual Insurance Company on its acquisition of West Virginia Mutual Insurance Company
April 20, 2022
Checklist for Non-U.S. Fund Managers Making a Private Fund Offering in the U.S.
March 22, 2022
SEC Investment Adviser Marketing Rule: Compliance Date is Nov. 4, 2022
February 24, 2022
SEC Issues Significant Private Fund Proposal: Standardized Prohibitions and Requirements
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
August 9, 2021
King & Spalding Team Closes a Variety of Esoteric Financings in Early 2021
December 2, 2020
K&S counsels MAG Mutual Insurance Company on its acquisition of West Virginia Mutual Insurance Company
April 20, 2022
Checklist for Non-U.S. Fund Managers Making a Private Fund Offering in the U.S.
March 22, 2022
SEC Investment Adviser Marketing Rule: Compliance Date is Nov. 4, 2022
February 24, 2022
SEC Issues Significant Private Fund Proposal: Standardized Prohibitions and Requirements
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
August 9, 2021
King & Spalding Team Closes a Variety of Esoteric Financings in Early 2021
December 2, 2020
K&S counsels MAG Mutual Insurance Company on its acquisition of West Virginia Mutual Insurance Company
LL.M., Humboldt University of Berlin
B.Sc., University of Tasmania
LL.B., University of Tasmania
England and Wales
New South Wales
New York
German